Biohaven Ltd. (BHVN)
NYSE·Healthcare·Biotechnology
$15.51
+1.44%
Mkt Cap $2.10B
Analyst Ratings
Buy
4
Hold
2
Sell
1
Price Target (31 analysts)
$20.00
Range $11.00 – $30.00
Implied Upside
+28.9%
Consensus $20.00 vs current $15.51
NYSE·Healthcare·Biotechnology
$15.51
+1.44%
Mkt Cap $2.10B
Buy
4
Hold
2
Sell
1
Price Target (31 analysts)
$20.00
Range $11.00 – $30.00
+28.9%
Consensus $20.00 vs current $15.51